New real-world studies show Vraylar boosts depression relief, functioning, and quality of life in MDD and bipolar I patients beyond clinical trials.
|Poll|May 11, 2015
Check Your Bipolar Acumen
Author(s)Psychiatric Times Editors
Lithium, neuroimaging, and medical comorbidities in bipolar disorder: here's a 3 question mini-quiz from the very recent literature.
Advertisement
Three questions from the very recent literature about bipolar disorder follow.
1. Which of the following statements about lithium therapy in patients with bipolar disorder is true?
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Insights on the New Adult ADHD Guidelines: A Conversation With the President of APSARD
2
Centanafadine For Comorbid ADHD and Anxiety: Talking New Data With John Kraus, MD, PhD
3
FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval
4
New Adult ADHD Guidelines: What Resources Are Coming Soon
5